Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Allotment

 The Allotment Committee of the Board of Directors of the Company, in its meeting held today i.e. 25th June 2020 has allotted 4,00,000 (Four Lakh) Fully Paid up Equity Shares of Rs 10/- each at a premium of Rs 195/- per share to M/s NCVI Enterprises Limited (promoter group company) upon exercise of the option attached with the Warrants allotted on 30th March 2019. The said shares shall remain locked-in for a period of 3 years from the date of trading approval. Consequent upon issue of the abovesaid 4,00,000 Equity Shares, the total paid-up capital of the Company stands increased at Rs 58,70,55,020 (Rupees Fifty Eight Crore Seventy Lakh Fifty Five Thousand Twenty Only) divided into 5,87,05,502 (Five Crore Eighty Seven Lakh Five Thousand Five Hundred Two) Fully Paid up Equity Shares of Rs 10/- each. With the conversion of the above said 4,00,000 Warrants into equity shares, now no Warrants are outstanding for conversion. The meeting was concluded at 2:30 PM
25-06-2020
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for NCVI Enterprises Ltd & Others
20-06-2020
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Allotment

 This is to inform you that the Allotment Committee of the Board of Directors of the Company, in its meeting held today i.e. 17th June 2020 at 11:00 AM has allotted 7,18,000 (Seven Lakh Eighteen Thousand) Fully Paid up Equity Shares of Rs 10/- each at a premium of Rs 195/- per share to M/s NCVI Enterprises Limited (promoter group company) upon exercise of the option attached with the Warrants allotted on 30th March 2019. The said shares shall remain locked-in for a period of 3 years from the date of trading approval. Consequent upon issue of the abovesaid 7,18,000 Equity Shares, the total paid-up capital of the Company stands increased at Rs 58,30,55,020 (Rupees Fifty Eight Crore Thirty Lakh Fifty Five Thoudand Twenty Only) divided into 5,83,05,502 (Five Crore Eighty Three Lakh Five Thoudand Five Hundred Two) fully paid equity shares of Rs 10/- each. The meeting was concluded at 11:20 AM. This is for your information & record please.
17-06-2020
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to the provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith copies of the newspaper publication of audited financial results for the quarter and year ended 31st March 2020 published in Economic Times, Business Standard, Financial Express and Punjabi Jagran on 13th June 2020.
15-06-2020

IOL Chemicals Standalone March 2020 Net Sales at Rs 441.46 crore, up 4.54% Y-o-Y

 NULL
15-06-2020
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Press Release with respect to Audited Financial Results for the quarter and year ended 31st March 2020.
12-06-2020
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 We are enclosing herewith Annual Secretarial Compliance Report issued by M/s B.K. Gupta & Associates, Company Secretaries in compliance with Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended 31st March 2020. This is for your information & record.
12-06-2020
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Disclosure Of Related Party Transactions

 Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed herewith Disclosure of related party transactions for the year ended 31st March 2020. This is for your information & record.
12-06-2020
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Statement Of Deviation Or Variation For Proceeds Of Warrants Issued On Preferential Basis On March 2019

 With reference to the captioned subject and pursuant to Regulations 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Circular No.: CIR/CFD/CMD1/162/2019 dated 24.12.2019, please find enclosed herewith Statement of Deviation or Variation for proceeds of warrants issued on preferential basis on March 2019. The aforesaid statement has also been reviewed by the Audit and Risk Management Committee in its meeting held on 12.06.2020. This is for your information & record.
12-06-2020
Bigul

IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Outcome Of The Board Meeting Dated 12Th June 2020 And Submission Of Audited Financial Results For The Quarter And Year Ended 31St March 2020.

 Pursuant to Regulations 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on today i.e. 12th June 2020 has interalia considered and approved: 1. Audited Financial Results for the Quarter and Year ended 31st March 2020. Copy of the said financial results along with unmodified Auditors Report thereon is enclosed herewith. 2. Re-appointment of Mr Vikas Gupta as Executive Director of the Company for five years with effect from 29 May 2020 to 28 May 2025, subject to the approval of the members. We hereby confirm and declare that Auditors Report issued by the Statutory Auditors on the financial results of the Company for the financial year ended 31st March 2020 is an unmodified report. The meeting of Board of Directors commenced at 04:15 PM and concluded at 06:00 PM.
12-06-2020
Next Page
Close

Let's Open Free Demat Account